Print

NeurOp Corporation Announces Drug Discovery Collaboration with Bristol-Myers Squibb Company (BMY)  
3/30/2010 10:18:25 AM

ATLANTA--(BUSINESS WIRE)--NeurOp Corporation today announced a collaboration with Bristol-Myers Squibb Company (NYSE: BMY) focused upon the development of NeurOp’s proprietary small molecules for use in the treatment of major depression and other central nervous system disorders.
//-->